Amgen
AMGN
#94
Rank
HK$1.425 T
Marketcap
HK$2,648
Share price
-1.52%
Change (1 day)
25.34%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

P/S ratio for Amgen (AMGN)

P/S ratio as of December 2025 (TTM): 5.09

According to Amgen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 19.0. At the end of 2025 the company had a P/S ratio of 4.09.

P/S ratio history for Amgen from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20254.09-3.28%
20244.22-22.75%
20235.472.71%
20225.329.15%
20214.88-7.35%
20205.26-13.73%
20196.1018.24%
20185.16-6.58%
20175.5216.78%
20164.73-16.27%
20155.65-6.41%
20146.0430.98%
20134.6122.07%
20123.784.54%
20113.616.26%
20103.40-11.58%
20093.84-4.61%
20084.0317.93%
20073.42-38.78%
20065.58-28.11%
20057.771.36%
20047.66-19.29%
20039.49-17.08%
200211.4-23.23%
200114.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.33-54.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.20-56.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
2.31-54.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
5.23 2.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
2.65-47.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
6.78 33.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.29 3.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
4.59-9.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
15.3 200.57%๐Ÿ‡บ๐Ÿ‡ธ USA